Abstract
Background: Endothelial dysfunction is a key early event in atherosclerosis that occurs in acute coronary syndrome. It was reported that atorvastatin improves the endothelial function of skeletal muscle vessels, but the effect on the coronary artery is unknown.
Hypothesis: The purpose of this study is to determine the effects of atorvastatin on coronary endothelial function in humans.
Methods: Non‐infarct‐related coronary arteries of 48 patients with acute myocardial infarction who had undergone successful percutaneous transluminal coronary angioplasty were examined. Three groups were studied: hyperlipidemia with use of atorvastatin (Group 1, n = 17), hyperlipidemia without statin use (Group 2, n = 18), and normal cholesterol level controls (Group 3, n = 13). Statin treatment was started at discharge. Acetylcholine (Ach) was infused into the coronary artery and the diameter was assessed by quantitative angiography at baseline and after 6 months.
Results: Acetylcholine given in doses of 1, 3, 10, and 30 mg/min increased the coronary artery diameter change in a dose‐dependent manner. In the initial study, patients in the three groups had similar responses to Ach. The mean diameter change after 6 months was significantly improved in Group 1 compared with Groups 2 and 3 (−11 ± 3 % vs. −20 ± 7% and −21 ± 6 %, respectively; p< 0.01 in each case). Multivariate regression analysis showed that atorvastatin (p < 0.01) was the significant determinant for improvement of endothelial function.
Conclusions: These findings suggest that atorvastatin improves endothelial function of the coronary artery in patients with myocardial infarction.
Keywords: endothelium, lipids, hypercholesterolemia, myocardial infarction
Full Text
The Full Text of this article is available as a PDF (492.5 KB).
Reference
- 1. Randomised trial of cholesterol lowering in 4,444 patients with coronary heart disease: The Scandinavian Simvastatin Survival Study (4S). Lancet 1994; 344: 1383–1389 [PubMed] [Google Scholar]
- 2. Sacks FM, Pfeffer MA, Moyé LA, Rouleau JL, Rutherford JD, Cole TG, Brown L, Warnica JW, Arnold JM, Wun CC, Davis BR, Braunwald E: The effect of pravastatin on coronary events after myocardial infarction in patients with average cholesterol levels. N Engl J Med 1996; 335: 1001–1009 [DOI] [PubMed] [Google Scholar]
- 3. The Long‐term Intervention with Pravastatin in Ischaemic Disease (LIPID) Study Group: Prevention of cardiovascular events and death with pravastatin in patients with coronary heart disease and a broad range of initial cholesterol levels: The Long‐Term Intervention with Pravastatin in Ischaemic Disease (LIPID) Study Group. N Engl J Med 1998; 339: 1349–1357 [DOI] [PubMed] [Google Scholar]
- 4. Schartl M, Bocksch W, Koschyk DH, Voelker W, Karsch KR, Kreuzer J, Hausmann D, Beckmann S, Gross M: Use of intravascular ultrasound to compare effects of different strategies of lipid‐lowering therapy on plaque volume and composition in patients with coronary artery disease. Circulation 2001; 104: 387–392 [DOI] [PubMed] [Google Scholar]
- 5. Maron DJ, Fazio S, Linton MF: Current perspectives on statins. Circulation 2000; 101: 207–213 [DOI] [PubMed] [Google Scholar]
- 6. Kent SM, Flaherty PJ, Coyle LC, Markwood TT, Taylor AJ: Effect of atorvastatin and pravastatin on serum C‐reactive protein. Am Heart J 2003; 145 (2): e8 [DOI] [PubMed] [Google Scholar]
- 7. Dujovne CA, Harris WS, Altman R, Overhiser RW, Black DM: Effect of atorvastatin on hemorheologic‐hemostatic parameters and serum fibrinogen levels in hyperlipidemic patients. Am J Cardiol 2000; 85: 350–353 [DOI] [PubMed] [Google Scholar]
- 8. Laufs U, Fata VL, Plutzky J, Liao JK: Upregulation of endothelial nitric oxide synthase by HMG CoA reductase inhibitors. Circulation 1998; 97: 1129–1135 [DOI] [PubMed] [Google Scholar]
- 9. Lazar HL, Bao Y, Zhang Y, Bernard SA: Pretreatment with statins enhances myocardial protection during coronary revascularization. J Thorac Cardiovasc Surg 2003; 125: 1037–1042 [DOI] [PubMed] [Google Scholar]
- 10. Simons LA, Sullivan D, Simons J, Celermajer DS: Effects of atorvastatin monotherapy and simvastatin plus cholestyramine on arterial endothelial function in patients with severe primary hypercholesterolaemia. Atherosclerosis 1998; 137: 197–203 [DOI] [PubMed] [Google Scholar]
- 11. Taylor AJ, Kent SM, Flaherty PJ, Coyle LC, Markwood TT, Vernalis MN: ARBITER: Arterial Biology for the Investigation of the Treatment Effects of Reducing cholesterol: A randomized trial comparing the effects of atorvastatin and pravastatin on carotid intima medial thickness. Circulation 2002; 106: 2055–2060 [DOI] [PubMed] [Google Scholar]
- 12. Furchgott RF, Zawadzki JV: The obligatory role of endothelial cells in the relaxation of arterial smooth muscle by acetylcholine. Nature 1980; 288: 373–276 [DOI] [PubMed] [Google Scholar]
- 13. Vanhoutte PM: Endothelial control of vasomotor function: From health to coronary disease. Circ J 2003; 67: 572–575 [DOI] [PubMed] [Google Scholar]
- 14. See VY Jr, DeNofrio D, Goldberg L, Chang G, Sasseen B, Kolansky DM, Pickering F, Kao A, Loh E, Wilensky RL: Effect of atorvastatin on postcardiac transplant increase in low‐density lipoprotein cholesterol reduces development of intimal hyperplasia and progression of endothelial dysfunction. Am J Cardiol 2003; 92: 11–15 [DOI] [PubMed] [Google Scholar]
- 15. Lekakis JP, Papamichael CM, Barbaki P, Papaioannou TG, Stamatelopoulos KS, Dagre AG, Stamatelopoulos SF: Comparison of low‐density lipoprotein cholesterol lowering by pravastatin to < 100 mg/dl versus > 100 mg/dl on brachial artery vasoreactivity in patients with severe hypercholesterolemia and previous atherosclerotic events or diabetes mellitus. Am J Cardiol 2002; 89: 857–860 [DOI] [PubMed] [Google Scholar]
- 16. ENCORE Investigators: Effect of nifedipine and cerivastatin on coronary endothelial function in patients with coronary artery disease: The ENCORE I Study (Evaluation of Nifedipine and Cerivastatin On Recovery of coronary Endothelial function). Circulation 2003. 28;107: 422–428 [DOI] [PubMed] [Google Scholar]
- 17. Masumoto A, Hirooka Y, Hironaga K, Eshima K, Setoguchi S, Egashira K, Takeshita A: Effect of pravastatin on endothelial function in patients with coronary artery disease (cholesterol‐independent effect of pravastatin). Am J Cardiol 2001; 88: 1291–1294 [DOI] [PubMed] [Google Scholar]
- 18. Dimmeler S, Zeiher AM: Akt takes center stage in angiogenesis signaling. Circ Res 2000; 86: 4–5 [DOI] [PubMed] [Google Scholar]
- 19. Bernal‐Mizrachi L, Jy W, Jimenez JJ, Pastor J, Mauro LM, Horstman LL, de Marchena E, Ahn YS: High levels of circulating endothelial microparticles in patients with acute coronary syndromes. Am Heart J 2003; 145: 962–970 [DOI] [PubMed] [Google Scholar]
- 20. Sata M, Kakoki M, Nagata D, Nishimatsu H, Suzuki E, Aoyagi T, Sugiura S, Kojima H, Nagano T, Kangawa K, Matsuo H, Omata M, Nagai R, Hirata Y: Adrenomedullin and nitric oxide inhibit human endothelial cell apoptosis via a cyclic GMP‐independent mechanism. Hypertension 2000; 36: 83–88 [DOI] [PubMed] [Google Scholar]
- 21. Vasa M, Fichtlscherer S, Adler K, Aicher A, Martin H, Zeiher AM, Dimmeler S: Increase in circulating endothelial progenitor cells by statin therapy in patients with stable coronary artery disease. Circulation 2001; 103: 2885–2890 [DOI] [PubMed] [Google Scholar]
- 22. Treasure CB, Klein JL, Weintraub WS, Talley JD, Stillabower ME, Kosinski AS, Zhang J, Boccuzzi SJ, Cedarholm JC, Alexander RW: Beneficial effects of cholesterol‐lowering therapy on the coronary endothelium in patients with coronary artery disease. N Engl J Med 1995; 332: 481–487 [DOI] [PubMed] [Google Scholar]
- 23. Anderson TJ, Meredith IT, Yeung AC, Frei B, Selwyn AP, Ganz P: The effect of cholesterol‐lowering and antioxidant therapy on endothelium‐dependent coronary vasomotion. N Engl J Med 1995; 332: 488–493 [DOI] [PubMed] [Google Scholar]
- 24. Egashira K, Hirooka Y, Kai H, Sugimachi M, Suzuki S, Inou T, Takeshita A: Reduction in serum cholesterol with pravastatin improves endothelium‐dependent coronary vasomotion in patients with hypercholesterolemia. Circulation 1994; 89: 2519–2524 [DOI] [PubMed] [Google Scholar]
- 25. Sakabe K, Fukuda N, Wakayama K, Nada T, Shinohara H, Tamura Y: Effects of atorvastatin therapy on the low‐density lipoprotein subfraction, remnant‐like particles cholesterol, and oxidized low‐density lipoprotein within 2 weeks in hypercholesterolemic patients. Circ J 2003; 67: 866–870 [DOI] [PubMed] [Google Scholar]